Geode Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.9M | Buy |
1,241,296
+103,798
| +9% | +$861K | ﹤0.01% | 2319 |
|
|
2026
Q1 | $9.53M | Sell |
1,137,498
-7,708
| -0.7% | -$81K | ﹤0.01% | 2408 |
|
|
2025
Q4 | $16.5M | Buy |
1,145,206
+19,658
| +2% | +$245K | ﹤0.01% | 2115 |
|
|
2025
Q3 | $10.9M | Sell |
1,125,548
-2,973
| -0.3% | -$26.3K | ﹤0.01% | 2374 |
|
|
2025
Q2 | $9.27M | Buy |
1,128,521
+21,575
| +2% | +$181K | ﹤0.01% | 2417 |
|
|
2025
Q1 | $7.92M | Buy |
1,106,946
+12,721
| +1% | +$94.6K | ﹤0.01% | 2429 |
|
|
2024
Q4 | $8.46M | Buy |
1,094,225
+5,574
| +0.5% | +$52.3K | ﹤0.01% | 2472 |
|
|
2024
Q3 | $11.4M | Buy |
1,088,651
+44,037
| +4% | +$537K | ﹤0.01% | 2299 |
|
|
2024
Q2 | $12.2M | Buy |
1,044,614
+94,063
| +10% | +$1.46M | ﹤0.01% | 2205 |
|
|
2024
Q1 | $20M | Buy |
950,551
+20,879
| +2% | +$372K | ﹤0.01% | 1930 |
|
|
2023
Q4 | $16.7M | Buy |
929,672
+46,526
| +5% | +$820K | ﹤0.01% | 2023 |
|
|
2023
Q3 | $14.5M | Buy |
883,146
+69,617
| +9% | +$1.26M | ﹤0.01% | 2027 |
|
|
2023
Q2 | $16.3M | Buy |
813,529
+52,732
| +7% | +$1.02M | ﹤0.01% | 1994 |
|
|
2023
Q1 | $14.4M | Buy |
760,797
+27,552
| +4% | +$610K | ﹤0.01% | 2017 |
|
|
2022
Q4 | $16.6M | Buy |
733,245
+25,672
| +4% | +$580K | ﹤0.01% | 1899 |
|
|
2022
Q3 | $18.7M | Buy |
707,573
+7,805
| +1% | +$232K | ﹤0.01% | 1774 |
|
|
2022
Q2 | $17.3M | Buy |
699,768
+14,129
| +2% | +$353K | ﹤0.01% | 1861 |
|
|
2022
Q1 | $22.8M | Buy |
685,639
+17,786
| +3% | +$494K | ﹤0.01% | 1810 |
|
|
2021
Q4 | $21.8M | Buy |
667,853
+2,434
| +0.4% | +$82.9K | ﹤0.01% | 1898 |
|
|
2021
Q3 | $27.9M | Buy |
665,419
+2,711
| +0.4% | +$97.5K | ﹤0.01% | 1730 |
|
|
2021
Q2 | $25.7M | Buy |
662,708
+34,771
| +6% | +$1.24M | ﹤0.01% | 1793 |
|
|
2021
Q1 | $21.4M | Buy |
627,937
+104,749
| +20% | +$4.47M | ﹤0.01% | 1840 |
|
|
2020
Q4 | $23.7M | Buy |
523,188
+29,792
| +6% | +$1.04M | ﹤0.01% | 1608 |
|
|
2020
Q3 | $13.6M | Sell |
493,396
-17,282
| -3% | -$563K | ﹤0.01% | 1777 |
|
|
2020
Q2 | $18.8M | Buy |
510,678
+20,468
| +4% | +$763K | ﹤0.01% | 1553 |
|
|
2020
Q1 | $15.9M | Buy |
490,210
+28,988
| +6% | +$1.21M | ﹤0.01% | 1456 |
|
|
2019
Q4 | $18.9M | Buy |
461,222
+3,129
| +0.7% | +$124K | ﹤0.01% | 1600 |
|
|
2019
Q3 | $16.3M | Buy |
458,093
+25,802
| +6% | +$1.05M | ﹤0.01% | 1616 |
|
|
2019
Q2 | $22.2M | Buy |
432,291
+24,917
| +6% | +$1.24M | 0.01% | 1417 |
|
|
2019
Q1 | $23.3M | Buy |
407,374
+28,586
| +8% | +$1.42M | 0.01% | 1312 |
|
|
2018
Q4 | $15.9M | Buy |
378,788
+40,159
| +12% | +$2.36M | ﹤0.01% | 1447 |
|
|
2018
Q3 | $25.6M | Buy |
338,629
+41,462
| +14% | +$2.99M | 0.01% | 1228 |
|
|
2018
Q2 | $21.3M | Buy |
297,167
+36,755
| +14% | +$1.76M | 0.01% | 1300 |
|
|
2018
Q1 | $7.77M | Buy |
260,412
+12,084
| +5% | +$352K | ﹤0.01% | 1949 |
|
|
2017
Q4 | $8.26M | Buy |
248,328
+2,506
| +1% | +$75.5K | ﹤0.01% | 1878 |
|
|
2017
Q3 | $8.1M | Buy |
245,822
+15,915
| +7% | +$358K | ﹤0.01% | 1873 |
|
|
2017
Q2 | $4.54M | Buy |
229,907
+58,561
| +34% | +$1.13M | ﹤0.01% | 2213 |
|
|
2017
Q1 | $3.31M | Buy |
171,346
+5,949
| +4% | +$115K | ﹤0.01% | 2366 |
|
|
2016
Q4 | $3.07M | Buy |
165,397
+4,668
| +3% | +$89.2K | ﹤0.01% | 2378 |
|
|
2016
Q3 | $2.25M | Buy |
160,729
+90,158
| +128% | +$995K | ﹤0.01% | 2490 |
|
|
2016
Q2 | $564K | Buy |
70,571
+13,429
| +24% | +$149K | ﹤0.01% | 3178 |
|
|
2016
Q1 | $617K | Buy |
57,142
+8,255
| +17% | +$106K | ﹤0.01% | 3115 |
|
|
2015
Q4 | $811K | Buy |
+48,887
| New | +$970K | ﹤0.01% | 3023 |
|
Other funds holding RGNX
RG
Geode Capital Management's RGNX Position: Q2 2026 in Review
Geode Capital Management increased its Regenxbio (RGNX) stake by 9.1% in Q2 2026, buying an estimated $861K and bringing the position to 1,241,296 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2319.
Geode Capital Management first reported a position in RGNX in Q4 2015 and has held it in 43 quarters since. The position peaked at $27.9M in Q3 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Geode Capital Management held 1,241,296 shares of Regenxbio worth $14.9M as of Q2 2026.
- Geode Capital Management bought 103,798 Regenxbio shares in Q2 2026, an estimated $861K.
- Regenxbio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2319 holding.
- Geode Capital Management first reported a position in Regenxbio in Q4 2015 and has held it in 43 quarters since.
- Geode Capital Management's Regenxbio position peaked at $27.9M in Q3 2021.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.